Fast Track for Unlisted Drugs and Medical Devices: Provides priority access to over 460 domestically unlisted drugs and medical devices (such as ELITA femtosecond laser and ruxolitinib), covering 40 specialty areas including oncology, rare diseases, and ophthalmology.
Real-World Data Application: Accelerates the registration of international drugs and medical devices in China through clinical data; 21 products have already been approved for market launch using LeCheng Data.